UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Japanese journal of clinical oncology, ISSN 0368-2811, 05/2015, Volume 45, Issue 5, pp. 408 - 410
Chemo-gynecology | Molecular Dx | Gynecol-med | Life Sciences & Biomedicine | Oncology | Science & Technology | Piperazines - administration & dosage | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Folic Acid - administration & dosage | TOR Serine-Threonine Kinases - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - administration & dosage | Vinca Alkaloids - administration & dosage | Benzimidazoles - administration & dosage | Doxorubicin - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Antimetabolites, Antineoplastic - pharmacology | Female | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | Paclitaxel - administration & dosage | Everolimus | Ovarian Neoplasms - drug therapy | Recombinant Fusion Proteins - administration & dosage | Doxorubicin - administration & dosage | Sirolimus - analogs & derivatives | Folic Acid - analogs & derivatives | Phthalazines - administration & dosage | Pyrimidines - administration & dosage | Deoxycytidine - administration & dosage | Angiogenesis Inhibitors - pharmacology | Carboplatin - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors | Polyethylene Glycols - administration & dosage | Sirolimus - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Nivolumab | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Topotecan - administration & dosage | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3347 - 3353
Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Ovarian Neoplasms - mortality | Early Termination of Clinical Trials | Time Factors | Dioxoles - administration & dosage | Doxorubicin - analogs & derivatives | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Treatment Outcome | Tetrahydroisoquinolines - administration & dosage | Disease Progression | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Topotecan - administration & dosage | Aged | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1302 - 1308
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Female genital diseases | Doxorubicin - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Polyethylene Glycols - adverse effects | Drug Resistance, Neoplasm | Polyethylene Glycols - therapeutic use | Organoplatinum Compounds - pharmacology | Bevacizumab | Antibodies, Monoclonal, Humanized - administration & dosage | Doxorubicin - analogs & derivatives | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Paclitaxel - adverse effects | Topotecan - adverse effects | Topotecan - therapeutic use | Paclitaxel - therapeutic use | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Aged | Doxorubicin - adverse effects | Index Medicus
Journal Article
European journal of haematology, ISSN 0902-4441, 03/2010, Volume 84, Issue 3, pp. 266 - 270
dexamethasone | refractory disease | cyclophosphamide | thalidomide | transplantation | Hodgkin's lymphoma | Cyclophosphamide | Transplantation | Dexamethasone | Refractory disease | Thalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Salvage Therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Vinblastine - administration & dosage | Hodgkin Disease - surgery | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Organoplatinum Compounds - administration & dosage | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Deoxycytidine - administration & dosage | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Vidarabine - analogs & derivatives | Bleomycin - administration & dosage | Thalidomide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Mechlorethamine - administration & dosage | Vidarabine - administration & dosage | Peripheral Blood Stem Cell Transplantation | Deoxycytidine - analogs & derivatives | Carmustine - administration & dosage | Antimitotic agents | Stem cells | Antineoplastic agents | Hodgkin's disease | Steroids | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6441 - 6449
Life Sciences & Biomedicine | Oncology | Science & Technology | Drug-Related Side Effects and Adverse Reactions - blood | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Neuroblastoma - blood | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Dacarbazine - analogs & derivatives | Killer Cells, Natural - immunology | Camptothecin - administration & dosage | Female | Child | Neoplasm Recurrence, Local - blood | Neuroblastoma - pathology | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Dacarbazine - administration & dosage | Gangliosides - antagonists & inhibitors | Interleukin-2 Receptor alpha Subunit - blood | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cell- and Tissue-Based Therapy | Gangliosides - immunology | Disease-Free Survival | Ifosfamide - administration & dosage | Neuroblastoma - drug therapy | Adolescent | Topotecan - administration & dosage | Drug-Related Side Effects and Adverse Reactions - classification | Interleukin-2 - blood | Toxicity | Cytotoxicity | Malignancy | Neuroblastoma | Cerebrospinal fluid | Pain | Interleukin 2 | Surgery | Myelosuppression | Children | Natural killer cells | Antibody-dependent cell-mediated cytotoxicity | Thrombocytopenia | Immune response | Cytokines | Ifosfamide | Granulocyte-macrophage colony-stimulating factor | Hypersensitivity | Etoposide | Pharmacology | Patients | Irinotecan | Cyclophosphamide | Chemotherapy | Experimental design | Monoclonal antibodies | Carboplatin | Temozolomide | Pharmacokinetics | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 30, pp. 4707 - 4713
Life Sciences & Biomedicine | Oncology | Science & Technology | Obesity | Biological and medical sciences | Metabolic diseases | Medical sciences | Tumors | Body Mass Index | Cytosine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Body Weight | Obesity - drug therapy | Area Under Curve | Body Size | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Carboplatin - administration & dosage | Cytosine - administration & dosage | Metabolic Clearance Rate | Cisplatin - administration & dosage | Obesity - metabolism | Taxoids - administration & dosage | Adolescent | Topotecan - administration & dosage | Camptothecin - administration & dosage | Dioxolanes - administration & dosage | Body Surface Area | Paclitaxel - administration & dosage | Camptothecin - analogs & derivatives | Doxorubicin - administration & dosage | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1247 - 1258
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Ovarian Neoplasms - mortality | Protein Kinase Inhibitors - adverse effects | Angiogenesis Inhibitors - administration & dosage | Time Factors | Adult | Female | Angiogenesis Inhibitors - adverse effects | Ovarian Neoplasms - drug therapy | Platinum Compounds - adverse effects | Sorafenib - administration & dosage | Double-Blind Method | Drug Administration Schedule | Topoisomerase I Inhibitors - administration & dosage | Topotecan - adverse effects | Sorafenib - adverse effects | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Topoisomerase I Inhibitors - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Progression-Free Survival | Topotecan - administration & dosage | Aged | Platinum Compounds - administration & dosage | Germany | Clinical trials | Analysis | Ovarian cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2009, Volume 27, Issue 9, pp. 1419 - 1425
Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | Peritoneal Neoplasms - pathology | Deoxycytidine - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carboplatin - administration & dosage | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Peritoneal Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Doxorubicin - analogs & derivatives | Topotecan - administration & dosage | Female | Neoplasm Staging | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Deoxycytidine - analogs & derivatives | Doxorubicin - administration & dosage | Index Medicus | Original Reports | Gync19
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 10/2014, Volume 473, Issue 1-2, pp. 384 - 394
Nanoparticles | P-glycoprotein | Topotecan | Bioavailability | Tamoxifen | MCF-7 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Lactic Acid - chemistry | Nanoparticles - chemistry | Rats, Wistar | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Topoisomerase I Inhibitors - administration & dosage | Drug Carriers - administration & dosage | Tamoxifen - administration & dosage | Drug Carriers - chemistry | Intestinal Absorption | Topotecan - chemistry | Animals | Biological Transport | MCF-7 Cells | Polyglycolic Acid - chemistry | Tamoxifen - chemistry | Topotecan - administration & dosage | Female | Nanoparticles - administration & dosage | Antineoplastic Agents, Hormonal - chemistry | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Topoisomerase I Inhibitors - chemistry | Investigations | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 13, pp. 1309 - 1316
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Female genital diseases | Doxorubicin - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Drug Resistance, Neoplasm | Polyethylene Glycols - therapeutic use | Organoplatinum Compounds - pharmacology | Bevacizumab | Antibodies, Monoclonal, Humanized - administration & dosage | Doxorubicin - analogs & derivatives | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Self Report | Paclitaxel - adverse effects | Topotecan - adverse effects | Treatment Outcome | Topotecan - therapeutic use | Paclitaxel - therapeutic use | Polyethylene Glycols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Aged | Doxorubicin - adverse effects | Index Medicus | Gync20 | Psc7 | Gync19 | ORIGINAL REPORTS | Psc13
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2014, Volume 20, Issue 8, pp. 2104 - 2114
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Folic Acid - pharmacology | Paclitaxel - pharmacology | Taxoids - pharmacology | Humans | Antineoplastic Agents - administration & dosage | Folic Acid - administration & dosage | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Neoplasms, Experimental - pathology | Vinca Alkaloids - administration & dosage | Vinca Alkaloids - pharmacology | Camptothecin - administration & dosage | Mice, Inbred DBA | Antineoplastic Agents - pharmacology | Paclitaxel - administration & dosage | Camptothecin - analogs & derivatives | Doxorubicin - administration & dosage | Folic Acid - analogs & derivatives | Topotecan - pharmacology | Carboplatin - administration & dosage | Treatment Outcome | Cisplatin - pharmacology | Neoplasms - drug therapy | Drug Synergism | Xenograft Model Antitumor Assays | Taxoids - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Topotecan - administration & dosage | Cell Proliferation - drug effects | Mice, Inbred BALB C | HeLa Cells | Carboplatin - pharmacology | Neoplasms - pathology | Camptothecin - pharmacology | Neoplasms, Experimental - drug therapy | Doxorubicin - pharmacology | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 500 - 514
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Bone Neoplasms - secondary | Carboplatin - administration & dosage | Child, Preschool | Etoposide - administration & dosage | Infant | Male | Survival Rate | Lymphatic Metastasis | Busulfan - administration & dosage | Young Adult | Melphalan - administration & dosage | International Agencies | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Adolescent | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Staging | Child | Neuroblastoma - pathology | Medical colleges | Chemotherapy | Stem cells | Etoposide | Dosage and administration | Product development | Busulfan | Research institutes | Neuroblastoma | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article